nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinically relevant murine model unmasks a “two-hit” mechanism for reactivation and dissemination of cytomegalovirus after kidney transplant
|
Zhang, Zheng |
|
|
19 |
9 |
p. 2421-2433 |
artikel |
2 |
Acute renal transplant dysfunction in a living donor kidney transplant recipient
|
O’Neill, Stephen |
|
|
19 |
9 |
p. 2655-2657 |
artikel |
3 |
Amending a historic paradigm for selecting living kidney donors
|
Steiner, Robert W. |
|
|
19 |
9 |
p. 2405-2406 |
artikel |
4 |
American Journal of Transplantation: Volume 19, Number 9, September 2019
|
|
|
|
19 |
9 |
p. i |
artikel |
5 |
A prospective multicenter observational study of cell-mediated immunity as a predictor for cytomegalovirus infection in kidney transplant recipients
|
Kumar, Deepali |
|
|
19 |
9 |
p. 2505-2516 |
artikel |
6 |
Bariatric surgery for obese donors: A letter to the editor re: Montgomery et al
|
Brooks, Joseph T. |
|
|
19 |
9 |
p. 2660 |
artikel |
7 |
Bariatric surgery for prospective living kidney donors with obesity?
|
Montgomery, John R. |
|
|
19 |
9 |
p. 2415-2420 |
artikel |
8 |
Beyond death and graft survival—Variation in outcomes after kidney transplantation. Results from the NSQIP Transplant beta phase
|
Parekh, Justin R. |
|
|
19 |
9 |
p. 2622-2630 |
artikel |
9 |
Bi-organ paired exchange—Sentinel case of a liver-kidney swap
|
Torres, Ana-Marie |
|
|
19 |
9 |
p. 2646-2649 |
artikel |
10 |
BK polyomavirus and cytomegalovirus – a closer link than expected?
|
Pape, Lars |
|
|
19 |
9 |
p. 2401-2402 |
artikel |
11 |
Building a Braid: Patient, Transplant and Society
|
Pullen, Lara C. |
|
|
19 |
9 |
p. 2395-2396 |
artikel |
12 |
Cryptosporidiosis outbreaks — United States, 2009–2017
|
Gharpure, Radhika |
|
|
19 |
9 |
p. 2650-2654 |
artikel |
13 |
Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis
|
Giménez, Estela |
|
|
19 |
9 |
p. 2479-2494 |
artikel |
14 |
Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy
|
Reischig, Tomas |
|
|
19 |
9 |
p. 2457-2467 |
artikel |
15 |
Cytomegalovirus reactivation: Another reason to minimize graft ischemia/reperfusion
|
Cook, Charles H. |
|
|
19 |
9 |
p. 2399-2400 |
artikel |
16 |
De novo coccidioidomycosis among solid organ transplant recipients 1 or more years after transplant
|
Asbury, Kara |
|
|
19 |
9 |
p. 2517-2524 |
artikel |
17 |
Donor infection with multidrug resistant organisms: Should we change our approach to perioperative prophylaxis?
|
Kaul, Daniel R. |
|
|
19 |
9 |
p. 2403-2404 |
artikel |
18 |
Drug-induced alloreactivity: A new paradigm for allorecognition
|
D’Orsogna, Lloyd J. |
|
|
19 |
9 |
p. 2606-2613 |
artikel |
19 |
Early clinical experience of bacteriophage therapy in 3 lung transplant recipients
|
Aslam, Saima |
|
|
19 |
9 |
p. 2631-2639 |
artikel |
20 |
Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ
|
Porrett, Paige M. |
|
|
19 |
9 |
p. 2525-2532 |
artikel |
21 |
Enteric conversion after bladder-drained pancreas transplantation is not associated with worse allograft survival
|
Adler, Joel T. |
|
|
19 |
9 |
p. 2543-2549 |
artikel |
22 |
Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity
|
Cantarelli, Chiara |
|
|
19 |
9 |
p. 2407-2414 |
artikel |
23 |
Fatal diffuse pulmonary fat microemboli following reperfusion in liver transplantation with the use of marginal steatotic allografts
|
Rosenfeld, David M. |
|
|
19 |
9 |
p. 2640-2645 |
artikel |
24 |
Fibroblasts can have subsets too!
|
Alegre, Maria-Luisa |
|
|
19 |
9 |
p. 2397 |
artikel |
25 |
Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014-2017
|
Bixler, Danae |
|
|
19 |
9 |
p. 2570-2582 |
artikel |
26 |
Impact of US Public Health Service increased risk deceased donor designation on organ utilization
|
Sapiano, Mathew R.P. |
|
|
19 |
9 |
p. 2560-2569 |
artikel |
27 |
Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients
|
L’Huillier, Arnaud G. |
|
|
19 |
9 |
p. 2495-2504 |
artikel |
28 |
Lifetime ESKD risk stratification for living kidney donor studies
|
Gaillard, François |
|
|
19 |
9 |
p. 2658-2659 |
artikel |
29 |
Local VEGF-A blockade modulates the microenvironment of the corneal graft bed
|
Salabarria, Ann-Charlott |
|
|
19 |
9 |
p. 2446-2456 |
artikel |
30 |
Macrosteatosis is a huge problem in liver transplantation—however, not the only one we face
|
Moosburner, Simon |
|
|
19 |
9 |
p. 2661-2662 |
artikel |
31 |
Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss
|
Louis, Kevin |
|
|
19 |
9 |
p. 2434-2445 |
artikel |
32 |
National landscape of HIV+ to HIV+ kidney and liver transplantation in the United States
|
Wilk, Amber R. |
|
|
19 |
9 |
p. 2594-2605 |
artikel |
33 |
Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors
|
Jones, Jefferson M. |
|
|
19 |
9 |
p. 2583-2593 |
artikel |
34 |
Response to “Macrosteatosis is a huge problem in liver transplantation – however, not the only one we face”
|
Croome, Kristopher |
|
|
19 |
9 |
p. 2663 |
artikel |
35 |
Risk factors for multidrug-resistant organisms among deceased organ donors
|
Anesi, Judith A. |
|
|
19 |
9 |
p. 2468-2478 |
artikel |
36 |
The changing landscape of live kidney donation in the United States from 2005 to 2017
|
Al Ammary, Fawaz |
|
|
19 |
9 |
p. 2614-2621 |
artikel |
37 |
The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis
|
Croome, Kristopher P. |
|
|
19 |
9 |
p. 2550-2559 |
artikel |
38 |
Transplanting hepatitis C virus–infected hearts into uninfected recipients: A single-arm trial
|
McLean, Rhondalyn C. |
|
|
19 |
9 |
p. 2533-2542 |
artikel |